[Clinical experience with ceftazidime in the infectious disease of children].
Thirteen patients mainly with lower respiratory tract infections were treated with ceftazidime (CAZ). The drug was given intravenously in a dose of 11 approximately 34 mg per 1 kg of body weight 2 approximately 3 times per day. The clinical response to treatment was satisfactory in 10 patients (76.9%). There was no side effects. CAZ appears to be an safe and effective antibiotic for the treatment of children with bacterial infections.
D000367:Age Factors; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002442:Ceftazidime; D002511:Cephalosporins / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male
D002511:Cephalosporins; D002442:Ceftazidime